System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Research Support, Non-U.S. Gov't Epublish 7 citations

PubMed: 37965323 DOI: 10.3389/fimmu.2023.1239592

Myeloid deletion attenuates CFA-induced inflammation and pain in mice via ameliorating macrophage infiltration and inflammatory cytokine production.

Front Immunol 14:1239592

Authors: Xiaolong Dai, Lianlian Li, Xinrong Yan, Qianqian Fan, Ruizhen Wang, Wenhao Zhang, Weiwei Chen, Yang Liu, Jianghui Meng, Jiafu Wang

Affiliations

  • School of Life Sciences, Henan University, Kaifeng, China.
  • School of Biotechnology, Faculty of Science and Health, Dublin City University, Dublin, Ireland.
  • School of Life Sciences, Henan University, Kaifeng, China. School of Biotechnology, Faculty of Science and Health, Dublin City University, Dublin, Ireland.

Abstract

Persistent inflammation and associated pain significantly impact individuals' quality of life, posing substantial healthcare challenges. Proinflammatory cytokines, released by activated macrophages, play crucial roles in the development of chronic inflammatory conditions such as rheumatoid arthritis. To identify and evaluate potential therapeutic interventions targeting this process for mitigating inflammation and pain, we created myeloid cell-specific knockout of (vesicle-associated membrane protein 3) mice ( ) by crossing mice with newly engineered mice. Bone marrow-derived macrophages and peritoneal resident macrophages from mice exhibited a significant reduction in TNF-α and IL-6 release compared to control mice. Moreover, Vamp3 deficiency led to decreased paw edema and ankle joint swelling induced by intraplantar injection of complete Freund's adjuvant (CFA). Furthermore, Vamp3 depletion also mitigated CFA-induced mechanical allodynia and thermal hyperalgesia. Mechanistically, Vamp3 loss ameliorated the infiltration of macrophages in peripheral sites of the hind paw and resulted in reduced levels of TNF-α and IL-6 in the CFA-injected paw and serum. RT-qPCR analysis demonstrated downregulation of various inflammation-associated genes, including , , , , , , , and in the injected paw at the test day 14 following CFA administration. These findings highlight the novel role of Vamp3 in regulating inflammatory responses and suggest it as a potential therapeutic target for the development of novel Vamp-inactivating therapeutics, with potential applications in the management of inflammatory diseases.

MeSH

Cytokines, Immune System Diseases, Pain, Macrophages, Therapeutics, Arthritis, Rheumatoid, Neuropeptides, Vesicle-Associated Membrane Protein 3

Cited by